A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring

Enrolling by invitation · Not applicable

Conditions studied: Type 2 Diabetes

In brief

Continuous glucose monitoring (CGM) can help improve blood sugar management in type 2 diabetes. A sequential, multiple assignment, randomized trial will evaluate clinical pharmacists, community health workers, and telehealth in supporting CGM use to improve blood sugar control.

Key facts

Study ID: NCT05911256
Run by: University of Massachusetts, Worcester
People needed: 318
Starts: 2024-09-27
Expected to finish: 2028-03-01
Last updated by the study team: 2025-10-20

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age 25-75.
History of T2DM > 1 year.
Speak English or Spanish.
A1c ≥ 8% (within past 6 months) - with reduction if necessary based on recruitment.
eGFR (estimated glomerular filtration rate) > 30.
Willingness to use continuous glucose monitoring (CGM) and work with a community health worker (including home visits) and clinical pharmacist.

You may not qualify if…

Plans for weight reduction surgery or prescription weight loss medication (specific for weight loss, not GLP-1).
Current, recent, or planned use of CGM.
Current use of steroids.
Abuse of illicit drugs.
Pregnancy (or planned pregnancy).
Specific comorbidities (e.g., recent MI, TIA, CVA, malignancy, hemoglobinopathy, severe hypoglycemia, etc.).
Psychiatric disorder that may limit ability to perform study tasks
Skin changes that preclude use of sensor or allergy to adhesive.
Planning to leave geographic area within 12 months or distance from clinical site > 20 miles.
Participation in another study.

Where it is running

University of Massachusetts — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.